Jubilant Pharmova Limited has announced the successful allotment of 80,000 Unsecured, Rated, Listed, Redeemable Non-Convertible Debentures (NCDs). The total amount raised through this private placement is Rs. 800 crore. The Finance Committee of the company approved the allotment on November 5, 2026. These NCDs have a face value of Rs. 1,00,000 each and were issued at par. The debentures carry an interest rate of 8.50% per annum and have a tenure of 3 years.
Jubilant Pharmova Completes Rs. 800 Crore NCD Allotment
Jubilant Pharmova Limited has successfully completed the allotment of Non-Convertible Debentures (NCDs) aggregating to Rs. 800 crore through a private placement basis. The decision was made by the company’s Finance Committee during a meeting held on Thursday, November 5, 2026.
Key Details of the NCD Issue
The allotment comprises 80,000 Unsecured, Rated, Listed, Redeemable Non-Convertible Debentures. Each debenture has a face value of Rs. 1,00,000 and was issued at par. This issuance aims to raise a total of Rs. 800 crore. The occurrence of this event was on November 5, 2026, at 07:30 P.M. (IST).
Debenture Terms and Conditions
The NCDs are listed and have a tenure of 3 Years, with the date of allotment being November 5, 2026, and the maturity date set for November 5, 2028. The coupon or interest offered on these debentures is 8.50% per annum. The company has stated that there are no charges or security created over the assets related to these debentures, and there are no special rights, interests, or privileges attached to them.
Source: BSE
